CC-92480 is a cereblon E3 ubiquitin ligase modulating drug (CELMoD). CC-92480 shows high affinity to cereblon, resulting in potent antimyeloma activity .
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
靶点 |
|
描述 | Mezigdomide (CC-92480), classified as a cereblon E3 ubiquitin ligase modulating agent (CELMoD), functions as a molecular adhesive. It exhibits a strong binding affinity to cereblon, thereby demonstrating potent antimyeloma activity [1]. |
体外研究 | Mezigdomide represents the second-generation cereblon modulator. In PBMC cultures, Mezigdomide-induced depletion of Aiolos and Ikaros led to T cell activation and enhanced secretion of IL-2 and IFN-γ. Mezigdomide demonstrates efficacy in cell lines resistant to CC-5013, CC-4047, and CC-220. It induces apoptosis as a single agent and displays notable synergy with NSC 34521 [1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.76mL 0.35mL 0.18mL |
8.81mL 1.76mL 0.88mL |
17.62mL 3.52mL 1.76mL |
CAS号 | 2259648-80-9 |
分子式 | C32H30FN5O4 |
分子量 | 567.61 |
别名 | CC-92480 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Inert atmosphere,2-8°C |
溶解度 |
DMSO: 4 mg/mL(7.05 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |